Usefulness of baseline impedance in patients with proton pump inhibitor‐refractory nonerosive reflux disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|S1|36-40

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.S1, 2015-03, pp. : 36-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of eotaxin‐3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor‐responsive oesophageal eosinophilia and gastro‐oesophageal reflux disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 2, 2015-07 ,pp. : 231-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual‐dose proton pump inhibitor: Acotiamide plus usual‐dose proton pump inhibitor versus double‐dose proton pump inhibitor

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 3, 2018-03 ,pp. : 623-630

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 2, 2015-02 ,pp. : 220-228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton Pump Inhibitor Improves Breath Marker in Moderate Asthma with Gastroesophageal Reflux Disease

By  

Respiration, Vol. 74, Iss. 5, 2007-03 ,pp. : 558-564

Karger

Access to resources Recommend Favorite

Letter: proton pump inhibitor‐responsive oesophageal eosinophilia – more than just gastro‐oesophageal reflux disease. Authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 912-913

John Wiley & Sons Inc

Access to resources Recommend Favorite